Complete DiGeorge Anomaly (cDGA) is a rare disease affecting approximately 1 in 300,000 infants. Children with complete DiGeorge Anomaly are born without a thymus gland, resulting in primary immunodeficiency. The disease is almost uniformly fatal within the first 24 months of life if untreated.

If you know of a child with complete DiGeorge Anomaly, or are a physician interested in collaboration, please get in touch with the Enzyvant team at

For more information on RVT-802, an investigational thymic-tissue based therapy for the treatment of primary immunodeficiency resulting from congenital athymia associated with complete DiGeorge Anomaly CLICK HERE

For more information about complete DiGeorge Anomaly.